Análisis de la acción Orthofix Medical Inc (OFIX)OFIXOrthofix Medical Inc

Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Orthofix Medical Inc is currently priced at $9.17, which is significantly below the average analyst price target of $13. However, the stock has a negative RSI of 46.37, indicating a potential lack of momentum. The company has also reported a 38.21% year-to-date decline, raising concerns about its long-term viability. While there are positive signs such as a recent revenue beat and an increase in adjusted EBITDA guidance, the ongoing investigation into fiduciary breaches poses a significant risk. Therefore, it may be prudent to hold off on buying until there is more clarity on these issues.

7 analysts cover OFIX: 6 rate it Buy, 1 Hold and 0 Sell. The average price target is 21.33.